Company Presentation
Capital Markets Day
Presentation of the Capital Markets Day (PDF)
Webcast: Capital Markets Day
2021 Financial Year
Half-Year Report 2021 (PDF)
Presentation of the Half-Year Results 2021 (PDF)
Webcast: Half-Year Results 2021 | 18.08.2021 | 2:00 pm (Swiss time)
Alternative Performance Measures
View our
Archive of Financial Reports
Zur Rose Group: Excellent starting position for e-prescriptions set up and ecosystem strategy successfully continued
Zur Rose and the Swiss Association for the Blind and Visually Impaired make it easier for people with a visual impairment to take medication
Zur Rose Group successfully completed capital increase from authorised capital and sets placement price at CHF 290 per new share
Zur Rose Group decides on capital increase from authorised capital and starts accelerated bookbuilding to make full use of increasing market opportunities
Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes
Zur Rose Group: Board of Directors nominates Walter Oberhänsli as Chairman and appoints Walter Hess as new CEO
Faster and more secure access to the gematik e-prescription with eHealth-Tec: Compatible software development kit for software providers
Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering people with obesity to find relevant care for a better quality of life.
Zur Rose Group further extends European market leadership and successfully implements healthcare platform
Collaboration between Zur Rose Group and Novo Nordisk: The Zur Rose Group and Novo Nordisk combine their expertise to improve the health journeys of people with obesity
Zur Rose Group AG: Olaf Heinrich, Head Germany, is leaving the Zur Rose Group; his successor will be Walter Hess, Head Switzerland
Zur Rose Group: gematik awards tender for specialist e-prescription service - Zur Rose subsidiary eHealth-Tec involved as partner to IBM
Allianz Care, CSS, Visana and Zur Rose Group in ground-breaking digital healthcare platform partnership
Zur Rose Group reinforces European market leadership by rigorously implementing the growth and platform strategy
Zur Rose Group successfully concluded acquisition of the e-commerce and diabetes activities of Apotal Group
Zur Rose Group successfully completed capital increase from authorized capital and sets placement price
Zur Rose Group strengthens European market leadership through acquisition of mail-order and diabetes activities of Apotal Group
Zur Rose Group: Charges in connection with mail-order of non-prescription drugs and electronic prescribing
Zur Rose Group AG publishes adjusted proposal for the creation of authorized share capital and withdraws the agenda item relating to the creation of additional conditional capital for the Annual General Meeting 2020
Zur Rose Group AG successfully completes the placement of CHF 175 million Convertible Bonds due 2025
Zur Rose Group AG launches CHF 150 million Convertible Bonds due 2025 with up to CHF 25 million increase option
COVID-19: Zur Rose is calling for an exception allowing the mail-orders for over-the-counter emergency, cold and flu medicines
Zur Rose Group: Purchase price payment for medpex acquisition completed early by earn-out settlement
Cooperation between Medbase and Zur Rose: The two joint ventures between Zur Rose and Medbase will commence operations at the start of the year
Cooperation between Migros and Zur Rose: Zur Rose and Migros open the first shop-in-shop pharmacy in French-speaking Switzerland
Zur Rose Group successfully concludes rights issue and announces offer price of CHF 93 per new share
Zur Rose Group AG: Statement on the draft coalition agreement in Germany: Rx mail-order ban not to be justified
Strategic collaboration between Zur Rose and Medbase: Combination of medical and pharmaceutical competence and exclusive supply of drugs to Medbase Centres
Extraordinary General Meeting of Zur Rose Group AG: Shareholders approve creation of authorised capital and revision to Articles of Association for initial public offering (IPO)
No search results
